|
|
| Discussions for Sinovac Biotech Ltd. | View all discussions |
|
| Phase III trial data of a small cap company's upcoming obesity drug | ||
| All 2 messages in discussion - | ||
From: tanu <tanumoydutta1...@gmail.com>
Date: Wed, 1 Jul 2009 04:59:08 -0700 (PDT)
Local: Wed, Jul 1 2009 7:59 am
Subject: Phase III trial data of a small cap company's upcoming obesity drug
Small cap company to release Phase 3 data on their Obesity drug. If
results are good, it will result in huge interest in the company and its stock. To read about which company, what drug, how it targets obesity, how its different from existing drugs targeting obesity, estimated market penetration of approved, etc., get a FREE report at: http://www.newbiomedicine.com You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
| ||||||||||||||
From: The Artist <The_art_is_ch...@hotmail.com>
Date: Wed, 1 Jul 2009 08:17:17 -0700 (PDT)
Local: Wed, Jul 1 2009 11:17 am
Subject: Re: Phase III trial data of a small cap company's upcoming obesity drug
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
| ||||||||||||||
| End of messages |
| « Newer discussion - CPD !!! Caraco’s total number of ANDAs pending approval by the FDA to 29 (including four tentative approvals) | Upcoming Phase 3 data of Obesity drug - Older discussion » |
| Google Home - Terms of Service - Privacy Policy |
©2009 Google